In prostate cancer, CHD1 co-localizes with H3K4me3 to the promoters of actively transcribed genes, while CHD1 depletion reduces H3K4me3 marked genes, alters the chromatin assembly across the genome, and reprograms the global transcription (22, 23, 25). Here, CHD1 is linked to prostate cancer.